Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    BMF-219

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Biomea Fusion Announces BMF-219 in Diabetes Placed on Clinical Hold
    Biomea Fusion Announces BMF-219 in Diabetes Placed on Clinical Hold

    06 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/06/2895065/0/en/Biomea-Fusion-Announces-BMF-219-in-Diabetes-Placed-on-Clinical-Hold.html

    GLOBENEWSWIRE
    06 Jun 2024
    Share Share
    Biomea Fusion Completes Enrollment 3 Arms BMF-219 Type 2 Diabetes Trial
    Biomea Fusion Completes Enrollment 3 Arms BMF-219 Type 2 Diabetes Trial

    30 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/30/2890844/0/en/Biomea-Fusion-Announces-Completion-of-Enrollment-of-First-3-Arms-in-Phase-2-Expansion-Cohorts-of-COVALENT-111-Study-for-BMF-219-in-Type-2-Diabetes.html

    GLOBENEWSWIRE
    30 May 2024
    Share Share